REGENXBIO
Samantha Yost is a Senior Scientist at REGENXBIO Inc. since March 2018, specializing in the structure-based design of AAV vectors for gene therapy. Major contributions include leading the establishment of a Biodistribution Core, pioneering new methods of structural characterization using cryo-electron microscopy in collaboration with Rutgers University, and enhancing AAV production efficiency. Prior experience includes roles at Bristol-Myers Squibb as a Research Scientist, where extensive work was done on CRISPR-edited gene knockout pools for immuno-oncology, and a postdoctoral position focusing on hepatitis C virus research at Rutgers University. Educational qualifications encompass a Ph.D. in Microbiology and Molecular Genetics from Rutgers University and advanced degrees in Biotechnology and Molecular Biology from Florida Institute of Technology.
This person is not in any teams
REGENXBIO
4 followers
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.